SI-BONE, Inc.

NASDAQ:SIBN

Medical - Devices

Healthcare
$23.54 +3.45%

+$0.53 today

Market cap
$1.06B
Beta
0.70
P/E (TTM)
-41.4
EPS (TTM)
-$0.38
52W Low $11.48High $21.89

Volume 1.12M

Average 0.68M

SIBN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

SI-BONE, Inc.NASDAQ: SIBN

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin holds steady near 79.8%

Gross margin was 79.8% in Q1 FY2026, up 0.0 pp from a year earlier. On a trailing-twelve-month basis it was 79.6%, up 0.3 pp year over year. Over 3 fiscal years it narrowed by 5.7 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
79.8%+0.7 pp QoQ
Last fiscal yearDec 2025
79.6%+0.5 pp YoY
LTMMar 2026
79.6%+0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.0 pp——
1 year+0.5 pp——
3 years-5.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
79.6%
Year-over-year change
+0.5pp

Gross Margin vs competitors

How SIBN compares with its peers on the latest reported figures

  • SIBN's LTM Mar 2026 gross margin of 79.6% is the highest of the 6 companies compared; the peer median is 65.3%.
  • Its year-over-year change of +0.3 pp is the 3rd highest of 6, against a peer median of -1.9 pp.
  • Over three fiscal years its change of -5.7 pp compares with a peer median of -1.9 pp.
SIBN Competitors Peer median
Gross Margin for SIBN and competitors
Company Period LTM level YoY 3-year change
SIBNSI-BONE, Inc.LTM Mar 202679.6% +0.3 pp-5.7 pp
GMEDGlobus Medical, Inc.LTM Jun 202668.5% +5.8 pp-6.8 pp
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
Peer median (excluding SIBN) 65.3%-1.9 pp-1.9 pp

Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue90.15M106.41M138.89M167.18M200.93M
Cost of Revenue10.43M15.71M29.47M35.06M41.05M
Gross Profit79.72M90.7M109.42M132.12M159.88M
Gross Margin88.4%85.2%78.8%79.0%79.6%
Research & Development12.44M13.63M15.03M16.56M17.45M
Selling, General & Admin118.95M136.69M141.32M150.81M164.76M
Operating Expenses131.39M150.31M156.35M167.37M182.21M
Depreciation & Amortization2.09M3.45M5.43M4.38M2.72M
EBITDA(50.97M)(54.99M)(34.45M)(23.09M)(10.91M)
EBITDA Margin-56.5%-51.7%-24.8%-13.8%-5.4%
Operating Income(51.67M)(59.61M)(46.93M)(35.25M)(22.33M)
Operating Margin-57.3%-56.0%-33.8%-21.1%-11.1%
Interest Income186K1.3M6.92M7.85M6.07M
Interest Expense5.37M2.82M3.46M3.44M5.28M
Other Income / Expenses(4.9M)(1.65M)3.6M4.34M3.42M
Income Before Tax(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Pre-Tax Margin-62.8%-57.6%-31.2%-18.5%-9.4%
Income Tax Expense00000
Net Income(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Net Margin-62.8%-57.6%-31.2%-18.5%-9.4%
EPS (Basic)(1.71)(1.79)(1.13)(0.75)(0.44)
EPS (Diluted)(1.71)(1.79)(1.13)(0.75)(0.44)
Weighted Avg Shares33.15M34.2M38.43M41.47M43.51M
Weighted Avg Shares (Diluted)33.15M34.2M38.43M41.47M43.51M

SI-BONE, Inc.

NASDAQ:SIBN

Intrinsic Alpha fair value

Locked

Current Price

$23.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.